Polydrug Use, Sexual Risk, and HIV Testing Among Cisgender Gay, Bisexual, and Other Men and Transgender and Nonbinary Individuals Who Have Sex With Men in Kazakhstan.
Yong Gun Lee, Gulnara Zhakupova, Vitaliy Vinogradov, Emily Allen Paine, Caitlin I Laughney, Kelsey Reeder, Alissa Davis, Timothy Hunt, Gaukhar Mergenova, Sholpan Primbetova, Assel Terlikbayeva, Elwin Wu
Author Information
Yong Gun Lee: Social Intervention Group, Columbia University School of Social Work, New York, New York.
Gulnara Zhakupova: Columbia University Global Health Research Center of Central Asia, Almaty, Kazakhstan.
Vitaliy Vinogradov: Columbia University Global Health Research Center of Central Asia, Almaty, Kazakhstan.
Emily Allen Paine: HIV Center for Clinical and Behavioral Studies, Columbia University and the New York Psychiatric Institute, New York, New York.
Caitlin I Laughney: Columbia University School of Social Work, New York, New York.
Kelsey Reeder: Columbia University School of Social Work, New York, New York.
Alissa Davis: Social Intervention Group, Columbia University School of Social Work, New York, New York.
Timothy Hunt: Social Intervention Group, Columbia University School of Social Work, New York, New York.
Gaukhar Mergenova: Columbia University Global Health Research Center of Central Asia, Almaty, Kazakhstan.
Sholpan Primbetova: Columbia University Global Health Research Center of Central Asia, Almaty, Kazakhstan.
Assel Terlikbayeva: Columbia University Global Health Research Center of Central Asia, Almaty, Kazakhstan.
Elwin Wu: Social Intervention Group, Columbia University School of Social Work, New York, New York.
中文译文
English
This study examined substance use and sexual risk correlates of HIV testing among cisgender gay, bisexual, and other men (MSM) and transgender and nonbinary individuals (TSM) who have sex with men in Kazakhstan. We analyzed baseline data from an HIV prevention trial collected prior to intervention deployment ( = 304). Multivariable logistic regression analyses revealed that lifetime HIV testing was positively associated with poly-drug use (AOR = 4.4, 95% CI [2.0, 9.9]) and negatively with sexual risk (AOR = 0.4, 95% CI [0.2, 1.0]). Similarly, recent HIV testing was positively associated with polydrug use (AOR = 2.7, 95% CI [1.4, 5.2]) and negatively with sexual risk (AOR = 0.5, 95% CI [0.3, 0.9]). Current HIV testing was negatively associated with sexual risk (AOR = 0.6, 95% CI [0.3. 0.9]). Findings support the value of integrating drug treatment with HIV testing among MSM and TSM in Kazakhstan.
Drug Alcohol Depend. 2000 Apr 1;59(1):17-31
[PMID: 10706972 ]
Clin Infect Dis. 2015 Dec 1;61(11):1732-41
[PMID: 26251048 ]
Curr Opin HIV AIDS. 2014 Mar;9(2):150-5
[PMID: 24406532 ]
PLoS One. 2015 May 14;10(5):e0126658
[PMID: 25973907 ]
Sci Rep. 2017 Nov 23;7(1):16117
[PMID: 29170407 ]
J Subst Use. 2017;22(1):53-59
[PMID: 30220879 ]
Drug Alcohol Depend. 2013 Nov;132 Suppl 1:S41-7
[PMID: 24103128 ]
AIDS Behav. 2021 Aug;25(8):2568-2577
[PMID: 33743115 ]
Int J Drug Policy. 2019 Jun;68:27-36
[PMID: 30981165 ]
BMC Public Health. 2021 Feb 15;21(1):354
[PMID: 33588816 ]
AIDS Behav. 2013 Oct;17(8):2742-55
[PMID: 23904147 ]
J Acquir Immune Defic Syndr. 2007 Apr 15;44(5):569-77
[PMID: 17310937 ]
J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):413-420
[PMID: 30080750 ]
LGBT Health. 2018 Nov/Dec;5(8):484-493
[PMID: 30481120 ]
Lancet HIV. 2014 Oct;1(1):e22-31
[PMID: 26423813 ]
AIDS Patient Care STDS. 2008 Sep;22(9):745-51
[PMID: 18754704 ]
Int J Drug Policy. 2017 May;43:33-43
[PMID: 28189979 ]
Drug Alcohol Depend. 2020 Nov 1;216:108237
[PMID: 33091811 ]
Drug Alcohol Depend. 2013 Nov;132 Suppl 1:S61-4
[PMID: 23916319 ]
J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 1:S32-6
[PMID: 21045597 ]
J Acquir Immune Defic Syndr. 2016 Aug 15;72 Suppl 3:S210-9
[PMID: 27429185 ]
PLoS One. 2014 Sep 15;9(9):e106760
[PMID: 25222010 ]
LGBT Health. 2017 Apr;4(2):164-167
[PMID: 28005454 ]
Arch Sex Behav. 2020 Jul;49(5):1463-1475
[PMID: 32394111 ]
AIDS Behav. 2016 Mar;20(3):590-9
[PMID: 26558629 ]
Pac AIDS Alert Bull. 1999;(18):15-6
[PMID: 12349391 ]
AIDS Educ Prev. 2018 Apr;30(2):96-107
[PMID: 29688773 ]
Behav Med. 2019 Oct-Dec;45(4):314-322
[PMID: 30605354 ]
Implement Sci. 2019 Jun 14;14(1):62
[PMID: 31200757 ]
Arch Sex Behav. 2015 Feb;44(2):421-8
[PMID: 25104104 ]
J Acquir Immune Defic Syndr. 2019 Jun 1;81(2):125-133
[PMID: 30844996 ]
Int J Drug Policy. 2021 Jun;92:103090
[PMID: 33513457 ]
PLoS One. 2012;7(8):e43071
[PMID: 22937013 ]
AIDS Behav. 2012 Aug;16(6):1394-410
[PMID: 22323004 ]
Int J Infect Dis. 2021 Mar;104:510-525
[PMID: 33385583 ]
Int J STD AIDS. 2017 May;28(6):594-601
[PMID: 27000299 ]
BMC Public Health. 2015 Aug 01;15:743
[PMID: 26231524 ]
Lancet. 2016 Sep 17;388(10050):1228-48
[PMID: 27427455 ]
BMJ Open. 2016 Feb 04;6(2):e010388
[PMID: 26846899 ]
R01 DA040513/NIDA NIH HHS
HIV Infections
HIV Testing
Homosexuality, Male
Humans
Kazakhstan
Male
Sexual Behavior
Sexual and Gender Minorities
Substance-Related Disorders
Transgender Persons